Invex Therapeutics Ltd (ASX:IXC)
Australia flag Australia · Delayed Price · Currency is AUD
0.0810
+0.0060 (8.00%)
Apr 30, 2025, 3:31 PM AEST

Invex Therapeutics Statistics

Total Valuation

ASX:IXC has a market cap or net worth of AUD 5.64 million. The enterprise value is -169,922.

Market Cap 5.64M
Enterprise Value -169,922

Important Dates

The next estimated earnings date is Wednesday, May 7, 2025.

Earnings Date May 7, 2025
Ex-Dividend Date n/a

Share Statistics

ASX:IXC has 75.15 million shares outstanding. The number of shares has increased by 0.62% in one year.

Current Share Class n/a
Shares Outstanding 75.15M
Shares Change (YoY) +0.62%
Shares Change (QoQ) +0.56%
Owned by Insiders (%) 26.31%
Owned by Institutions (%) 26.51%
Float 48.16M

Valuation Ratios

The trailing PE ratio is 49.64.

PE Ratio 49.64
Forward PE n/a
PS Ratio 4.65
PB Ratio 1.05
P/TBV Ratio 1.05
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -1.49
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 12.22

Current Ratio 12.22
Quick Ratio 12.22
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 2.14% and return on invested capital (ROIC) is -1.36%.

Return on Equity (ROE) 2.14%
Return on Assets (ROA) -1.20%
Return on Invested Capital (ROIC) -1.36%
Return on Capital Employed (ROCE) -2.16%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.20
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) 0.22
52-Week Price Change n/a
50-Day Moving Average 0.07
200-Day Moving Average 0.07
Relative Strength Index (RSI) 86.24
Average Volume (20 Days) 7,202

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, ASX:IXC had revenue of AUD 1.21 million and earned 114,355 in profits. Earnings per share was 0.00.

Revenue 1.21M
Gross Profit 1.21M
Operating Income -116,470
Pretax Income 114,355
Net Income 114,355
EBITDA n/a
EBIT -116,470
Earnings Per Share (EPS) 0.00
Full Income Statement

Balance Sheet

The company has 5.81 million in cash and n/a in debt, giving a net cash position of 5.81 million or 0.08 per share.

Cash & Cash Equivalents 5.81M
Total Debt n/a
Net Cash 5.81M
Net Cash Per Share 0.08
Equity (Book Value) 5.38M
Book Value Per Share 0.07
Working Capital 5.38M
Full Balance Sheet

Cash Flow

Operating Cash Flow -368,362
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -9.61% and 9.43%.

Gross Margin 100.00%
Operating Margin -9.61%
Pretax Margin 9.43%
Profit Margin 9.43%
EBITDA Margin n/a
EBIT Margin -9.61%
FCF Margin n/a

Dividends & Yields

ASX:IXC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield -0.62%
Shareholder Yield -0.62%
Earnings Yield 2.03%
FCF Yield n/a
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ASX:IXC has an Altman Z-Score of 3.88.

Altman Z-Score 3.88
Piotroski F-Score n/a